Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

[Effect of Biejiajian Pills on Wnt/β-catenin signal pathway and DKK-1 and FrpHe gene expressions in hepatocellular carcinoma cells].

He S, Cheng Y, Zhu Y, Fan Q, Sun H, Jia W.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Jan;33(1):30-3. Chinese.

2.

[Effect of Biejiajian Pills on Wnt signal pathway molecules β-catenin and GSK-3β and the target genes CD44v6 and VEGF in hepatocellular carcinoma cells].

Sun H, He S, Wen B, Jia W, Fan E, Zheng Y.

Nan Fang Yi Ke Da Xue Xue Bao. 2014 Oct;34(10):1454-8. Chinese.

3.
4.

[Inhibitory effect of Biejiajian pills on HepG2 cell xenograft growth and expression of β-catenin and Tbx3 in nude mice].

Wen B, Sun HT, He SQ, LA L, An HY, Pang J.

Nan Fang Yi Ke Da Xue Xue Bao. 2016 Feb;36(2):210-4. Chinese.

PMID:
26922018
5.

Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.

Qin X, Zhang H, Zhou X, Wang C, Zhang H, Zhang X, Ye L.

Transl Res. 2007 Nov;150(5):281-94. Epub 2007 Jul 18.

PMID:
17964517
6.

[The role and significance of Wnt/beta-catenin signaling pathway regulating the signaling molecules in hepatocellular carcinoma].

Wang XH, Sun X, Meng XW, Lü ZW, Liu MN, Pei FH.

Zhonghua Gan Zang Bing Za Zhi. 2010 Sep;18(9):672-5. doi: 10.3760/cma.j.issn.1007-3418.2010.09.007. Chinese.

PMID:
20943078
7.

Dichlorodiphenyltrichloroethane exposure induces the growth of hepatocellular carcinoma via Wnt/β-catenin pathway.

Jin XT, Song L, Zhao JY, Li ZY, Zhao MR, Liu WP.

Toxicol Lett. 2014 Feb 10;225(1):158-66. doi: 10.1016/j.toxlet.2013.12.006. Epub 2013 Dec 17.

PMID:
24355586
8.

The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene.

Wang B, Xunsun, Liu JY, Yang D, Yang LL, Kong DX, Meng XW.

Hepatogastroenterology. 2012 Mar-Apr;59(114):515-8. doi: 10.5754/hge11534.

PMID:
22024040
9.

In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.

Zhang ZC, Liu JX, Shao ZW, Pu FF, Wang BC, Wu Q, Zhang YK, Zeng XL, Guo XD, Yang SH, He TC.

Medicine (Baltimore). 2017 Jul;96(27):e7245. doi: 10.1097/MD.0000000000007245.

10.

DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway.

Chen L, Li M, Li Q, Wang CJ, Xie SQ.

Mol Cancer. 2013 Dec 10;12:157. doi: 10.1186/1476-4598-12-157.

11.

Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.

Ma L, Wang X, Jia T, Wei W, Chua MS, So S.

Oncotarget. 2015 Sep 22;6(28):25390-401. doi: 10.18632/oncotarget.4455.

12.

[Study on the role of Wnt/beta-catenin signaling transduction pathway in hepatocellular carcinoma cell line HepG2 and L02 cell line].

Wang QM, Jia LQ, Zhou HY, Li YS.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Oct;23(10):926-8. Chinese.

PMID:
17908501
13.

beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.

Wang XH, Sun X, Meng XW, Lv ZW, Du YJ, Zhu Y, Chen J, Kong DX, Jin SZ.

Oncol Rep. 2010 Oct;24(4):1093-9.

PMID:
20811694
14.

Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.

Lachenmayer A, Alsinet C, Savic R, Cabellos L, Toffanin S, Hoshida Y, Villanueva A, Minguez B, Newell P, Tsai HW, Barretina J, Thung S, Ward SC, Bruix J, Mazzaferro V, Schwartz M, Friedman SL, Llovet JM.

Clin Cancer Res. 2012 Sep 15;18(18):4997-5007. Epub 2012 Jul 18.

15.

Mammalian target of rapamycin regulates expression of β-catenin in hepatocellular carcinoma.

Feng Z, Fan X, Jiao Y, Ban K.

Hum Pathol. 2011 May;42(5):659-68. doi: 10.1016/j.humpath.2010.07.021. Epub 2011 Jan 15.

PMID:
21239045
16.

[Hydrocamptothecin promotes the mRNA expression of Wnt signaling inhibitor DKK-1].

LA L, Ban W, Rao JJ, Wu SG.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Apr;28(4):623-6. Chinese.

17.

Preliminary mechanism on the methylation modification of Dkk-1 and Dkk-3 in hepatocellular carcinoma.

Liang L, He H, Lv R, Zhang M, Huang H, An Z, Li S.

Tumour Biol. 2015 Feb;36(2):1245-50. doi: 10.1007/s13277-014-2750-y. Epub 2014 Oct 26.

PMID:
25344678
18.

Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.

Ueno K, Hirata H, Majid S, Chen Y, Zaman MS, Tabatabai ZL, Hinoda Y, Dahiya R.

Mol Carcinog. 2011 Jun;50(6):449-57. doi: 10.1002/mc.20729. Epub 2011 Jan 25.

PMID:
21268126
19.

Wnt/β-catenin signaling regulates MAPK and Akt1 expression and growth of hepatocellular carcinoma cells.

Wang XH, Meng XW, Sun X, Liu BR, Han MZ, DU YJ, Song YY, Xu W.

Neoplasma. 2011;58(3):239-44.

PMID:
21391741
20.

Inhibition of hepatocellular carcinoma by fulvestrant involves the estrogen receptor α and Wnt pathways in vitro and in patients.

Wang CJ, Guo DK, You TG, Shen DW, Wang C, Tang L, Wang J, Xu RH, Zhang H.

Mol Med Rep. 2014 Dec;10(6):3125-31. doi: 10.3892/mmr.2014.2595. Epub 2014 Sep 23.

PMID:
25270093

Supplemental Content

Support Center